Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
By automating the tracking of tumor cells that circulate in the blood, doctors can see if a cancer treatment is working.
A new microfluidics device gives results in 15 minutes.
In first human trial, particles successfully reach cancer cells and silence the target gene.
Molecules that make blood vessels more permeable might boost chemotherapeutics.
The fluorescent molecule targets tumors to guide surgeons and provide pre- and post-op imaging.
DNA changes could help doctors see if stray cancer cells remain after treatment.
Autoantibodies could alert doctors to cancer development.
An earlier measure of treatment could improve patients’ prognosis.
An infrared-based endoscope scans tissue below the surface.